IMB's latest news, explainers and more
Developing venom-based epilepsy drugs using lab-grown organs
Get the latest research to your inbox
- The toxin in the Australian stinging tree causes pain in a way never seen before, uncovering potential for new types of pain relief.
- Understanding how immune cells respond to the SARS-CoV-2 virus will help prevent runaway inflammation.
- IMB researchers have studied all four types of bacteria that cause sepsis to identify new targets for antibiotics.
- Laura Terry thought she was used to pain. But this pain was different.
- The first oral treatment for psoriasis has a successful clinical trial
- Professor David Craik has been recognised by the Australian Academy of Science, winning the David Craig Medal and Lecture, awarded to a researcher who has made a significant contribution to chemistry over their career.
- IMB researchers have contributed to the largest-ever genetic study of endometriosis, finding 42 regions across the genome associated with the disease.
- Genomic surveillance has detected a new strain of Strep A called M1uk in Australia
- A research collaboration with Moderna to develop a Strep A vaccine has secured $8 million in philanthropic funding.
Pages
Strawberry DNA extraction activity
Extract and view DNA from a strawberry using common household ingredients.
Get started
The Edge: Infection
The latest research and discovery
We are tackling the problem of drug-resistant bacteria through developing new diagnostics and treatments, and by empowering the community with knowledge on how to fight back against the threat of superbugs.
Subscribe to our newsletter
Get the latest research straight to your inbox.
Stay up-to-date as we answer questions about hot topics, and share the latest news at IMB, Australia’s #1 research institute.
General enquiries
+61 7 3346 2222
imb@imb.uq.edu.au
Media enquiries
IMB fully supports UQ's Reconciliation Action Plan and is implementing actions within our institute.
Support us
Donate to research
100% of donations go to the cause